Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
The use of inhibitors of the renin-angiotensin system
No-Receipt date
2007-03170 - 31/07/2007
No-Filing date
20070402374 - 31/07/2007
No-Granting date
3062743 - 31/07/2007
No-EPO application date
04021889.3 - 19/10/1998
No-EPO granting date
1498124 - 04/07/2007
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
7/2007 - 04/09/2007
Expiration date
20/10/2018
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
GB972202617/10/1997/GB
GB981085520/05/1998/GB
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
C12Q 1/00
A61P 25/00
A61K 31/662
A61K 31/66
A61K 31/554
A61K 31/551
A61K 31/55
A61K 31/519
A61K 31/472
A61K 31/44
A61K 31/4184
A61K 31/4178
A61K 31/417
A61K 31/415
A61K 31/41
A61K 31/407
A61K 31/405
A61K 31/403
A61K 31/401
A61K 31/40
A61K 31/223
A61K 31/22
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
216473
ARK THERAPEUTICS LIMITED
79 NEW CAVENDISH STREET
LONDON W1W 6XB
UNITED KINGDOM (GREAT BRITAIN)
216474
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BINGER STRASSE 173
55216 INGELHEIM AM RHEIN
GERMANY
Inventors
Code
Firstname
Surname
510126
MONTGOMERY, HUGH EDWARD
510127
MARTIN, JOHN FRANCIS BHF LABORATORIES DEP. OF
510128
ERUSALIMSKY, JORGE DANIEL
Representatives
Code
Firstname
Surname
Address
Town
Zip
403
CHRISTINA
DIMOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
4007
ELENI
PAPAKONSTANTINOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Payments history
13 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).